Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DOJ Anti-Fraud Actions Include $16M Kickback Settlement For Arthrex

Executive Summary

Arthrex reportedly paid a physician to use the company’s orthopedic products. Separately, multiple telehealth-related false-billing schemes landed six men in hot water.

You may also be interested in...



14 Health Care Professionals Ensnared In DOJ COVID-19 Fraud Enforcement

The crackdown, which was executed by the US DOJ’s new COVID-19 fraud task force, involves false claims in six states worth more than $143m.

US FDA Classifies 5 De Novo-Cleared Device Types

The five products include a conditioning tool for eating disorders, a system that evaluates the properties of esophogeal tissue, and a tool used to measure the strain on an orthopedic implant during surgery.

App Developers Turning To HIPAA Compliance In Face Of Growing State Data Privacy Constraints

Manufacturers faced with an increasingly complex landscape of state patient-privacy laws may opt to comply with federal Health Insurance Portability and Accountability Act regulations instead, attorney Brad Rostolsky tells Medtech Insight.

Topics

Related Companies

UsernamePublicRestriction

Register

MT144708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel